Literature DB >> 21095858

Point-of-care device for quantification of bilirubin in skin tissue.

Suresh K Alla1, Adam Huddle, Joshua D Butler, Peggy S Bowman, Joseph F Clark, Fred R Beyette.   

Abstract

Steady state diffuse reflectance spectroscopy is a nondestructive method for obtaining biochemical and physiological information from skin tissue. In medical conditions such as neonatal jaundice excess bilirubin in the blood stream diffuses into the surrounding tissue leading to a yellowing of the skin. Diffuse reflectance measurement of the skin tissue can provide real time assessment of the progression of a disease or a medical condition. Here we present a noninvasive point-of-care system that utilizes diffuse reflectance spectroscopy to quantifying bilirubin from skin reflectance spectra. The device consists of an optical system integrated with a signal processing algorithm. The device is then used as a platform to study two different spectral databases. The first spectral database is a jaundice animal model in which the jaundice reflectance spectra are synthesized from normal skin. The second spectral database is the spectral measurements collected on human volunteers to quantify the different chromophores and other physical properties of the tissue such as Hematocrit, Hemoglobin, etc. The initial trials from each of these spectral databases have laid the foundation to verify the performance of this bilirubin quantification device.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21095858     DOI: 10.1109/TBME.2010.2093132

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  2 in total

1.  Photoacoustic microscopy of bilirubin in tissue phantoms.

Authors:  Yong Zhou; Chi Zhang; Da-Kang Yao; Lihong V Wang
Journal:  J Biomed Opt       Date:  2012-12       Impact factor: 3.170

2.  The smartphone camera as a potential method for transcutaneous bilirubin measurement.

Authors:  Sarah B Munkholm; Tobias Krøgholt; Finn Ebbesen; Pal B Szecsi; Søren R Kristensen
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.